PennyStockPayCheck.com Rss

Featured Posts

Chase Bank Limits Cash Withdrawals, Bans International... Before you read this report, remember to sign up to http://pennystockpaycheck.com for 100% free stock alerts Chase Bank has moved to limit cash withdrawals while banning business customers from sending...

Read more

Richemont chairman Johann Rupert to take 'grey gap... Billionaire 62-year-old to take 12 months off from Cartier and Montblanc luxury goods groupRichemont's chairman and founder Johann Rupert is to take a year off from September, leaving management of the...

Read more

Cambodia: aftermath of fatal shoe factory collapse... Workers clear rubble following the collapse of a shoe factory in Kampong Speu, Cambodia, on Thursday

Read more

Spate of recent shock departures by 50-something CEOs While the rising financial rewards of running a modern multinational have been well publicised, executive recruiters say the pressures of the job have also been ratcheted upOn approaching his 60th birthday...

Read more

UK Uncut loses legal challenge over Goldman Sachs tax... While judge agreed the deal was 'not a glorious episode in the history of the Revenue', he ruled it was not unlawfulCampaign group UK Uncut Legal Action has lost its high court challenge over the legality...

Read more

Flu treatment boosts sales at Roche

Category : Business

Swiss drugmaker Roche reports a 5% rise in first quarter sales, helped by strong demand for its flu treatment, Tamiflu.

Here is the original post: Flu treatment boosts sales at Roche

Post to Twitter

Roche Holding Ltd (RHHBY: OTC Link) | Roche and Chiasma announce collaboration to develop and commercialize Chiasma’s Octreolin® for acromegaly and neuroendocrine tumors

Category : Stocks

< ?xml version="1.0" encoding="UTF-8"?>

Roche and Chiasma announce collaboration to develop and commercialize Chiasma’s Octreolin</p> <div class="tweetthis" style="text-align:left;"><p> <a target="_blank" rel="nofollow" class="tt" href="http://twitter.com/intent/tweet?text=Roche+Holding+Ltd+%28RHHBY%3A+OTC+Link%29+%7C+Roche+and+Chiasma+announce+collaboration+to+develop+and+...+http%3A%2F%2Fpennystockpaycheck.com%2Fnews%2F%3Fp%3D86856" title="Post to Twitter"><img class="nothumb" src="http://pennystockpaycheck.com/news/wp-content/plugins/tweet-this/icons/en/twitter/tt-twitter-micro3.png" alt="Post to Twitter" /></a></p></div> </div> </div> <div class="post-60907 post type-post status-publish format-standard hentry category-business category-world-news tag-boss tag-david tag-expedia tag-friday tag-group tag-hotels tag-part tag-president tag-roche" id="post-60907"> <div class="post_top"> <div class="post_title"> <h2><a href="http://pennystockpaycheck.com/news/?p=60907" rel="bookmark" title="Permanent Link to AUDIO: ‘I bought Hotels.com name for $11m’">AUDIO: ‘I bought Hotels.com name for $11m’</a></h2> </div> <div class="post_top_data"> <p class="post_author">Posted by <span>admin</span> | Posted on 04-11-2012</p> <p class="post_cats">Category : <span><a href="http://pennystockpaycheck.com/news/?cat=57" title="View all posts in Business" rel="category">Business</a>, <a href="http://pennystockpaycheck.com/news/?cat=4" title="View all posts in World News" rel="category">World News</a></span></p> <p class="post_tags">Tags: <span><a href="http://pennystockpaycheck.com/news/?tag=boss" rel="tag">boss</a>, <a href="http://pennystockpaycheck.com/news/?tag=david" rel="tag">david</a>, <a href="http://pennystockpaycheck.com/news/?tag=expedia" rel="tag">expedia</a>, <a href="http://pennystockpaycheck.com/news/?tag=friday" rel="tag">friday</a>, <a href="http://pennystockpaycheck.com/news/?tag=group" rel="tag">group</a>, <a href="http://pennystockpaycheck.com/news/?tag=hotels" rel="tag">hotels</a>, <a href="http://pennystockpaycheck.com/news/?tag=part" rel="tag">part</a>, <a href="http://pennystockpaycheck.com/news/?tag=president" rel="tag">president</a>, <a href="http://pennystockpaycheck.com/news/?tag=roche" rel="tag">roche</a></span></p> </div> </div> <div class="entry"> <p>Friday Boss: David Roche is president of Hotels.com which is part of the Expedia group.</p> </p> <p>Follow this link: <a target="_blank" href="http://news.bbc.co.uk/today/hi/today/newsid_9765000/9765923.stm#sa-ns_mchannel=rss&ns_source=PublicRSS20-sa" title="AUDIO: 'I bought Hotels.com name for $11m'">AUDIO: ‘I bought Hotels.com name for $11m’</a></p> <div class="tweetthis" style="text-align:left;"><p> <a target="_blank" rel="nofollow" class="tt" href="http://twitter.com/intent/tweet?text=AUDIO%3A+%E2%80%98I+bought+Hotels.com+name+for+%2411m%E2%80%99+http%3A%2F%2Fpennystockpaycheck.com%2Fnews%2F%3Fp%3D60907" title="Post to Twitter"><img class="nothumb" src="http://pennystockpaycheck.com/news/wp-content/plugins/tweet-this/icons/en/twitter/tt-twitter-micro3.png" alt="Post to Twitter" /></a></p></div> </div> </div> <div class="post-60557 post type-post status-publish format-standard hentry category-business tag-advanced tag-cancer tag-news tag-nhs tag-offered tag-roche tag-skin tag-the-guardian tag-treatment tag-turned tag-uk-news tag-vemurafenib" id="post-60557"> <div class="post_top"> <div class="post_title"> <h2><a href="http://pennystockpaycheck.com/news/?p=60557" rel="bookmark" title="Permanent Link to Skin cancer drug gets NHS go-ahead">Skin cancer drug gets NHS go-ahead</a></h2> </div> <div class="post_top_data"> <p class="post_author">Posted by <span>admin</span> | Posted on 02-11-2012</p> <p class="post_cats">Category : <span><a href="http://pennystockpaycheck.com/news/?cat=57" title="View all posts in Business" rel="category">Business</a></span></p> <p class="post_tags">Tags: <span><a href="http://pennystockpaycheck.com/news/?tag=advanced" rel="tag">advanced</a>, <a href="http://pennystockpaycheck.com/news/?tag=cancer" rel="tag">cancer</a>, <a href="http://pennystockpaycheck.com/news/?tag=news" rel="tag">news</a>, <a href="http://pennystockpaycheck.com/news/?tag=nhs" rel="tag">nhs</a>, <a href="http://pennystockpaycheck.com/news/?tag=offered" rel="tag">offered</a>, <a href="http://pennystockpaycheck.com/news/?tag=roche" rel="tag">roche</a>, <a href="http://pennystockpaycheck.com/news/?tag=skin" rel="tag">skin</a>, <a href="http://pennystockpaycheck.com/news/?tag=the-guardian" rel="tag">the guardian</a>, <a href="http://pennystockpaycheck.com/news/?tag=treatment" rel="tag">treatment</a>, <a href="http://pennystockpaycheck.com/news/?tag=turned" rel="tag">turned</a>, <a href="http://pennystockpaycheck.com/news/?tag=uk-news" rel="tag">uk news</a>, <a href="http://pennystockpaycheck.com/news/?tag=vemurafenib" rel="tag">vemurafenib</a></span></p> </div> </div> <div class="entry"> <p> <div><img alt="" src="http://hits.guardian.co.uk/b/ss/guardiangu-feeds/1/H.24.2.2/7356?ns=guardian&pageName=Skin+cancer+drug+gets+NHS+go-ahead%3AArticle%3A1823315&ch=Society&c3=Guardian&c4=Skin+cancer+%28Society%29%2CCancer+%28society%29%2CNHS+%28Society%29%2CHealth+%28Society%29%2CSociety%2CPharmaceuticals+industry+%28Business+sector%29%2CBusiness%2CUK+news&c5=Society+Weekly%2CUnclassified%2CNot+commercially+useful%2CBusiness+Markets%2CHealth+Society&c6=Sarah+Boseley&c7=12-Nov-02&c8=1823315&c9=Article&c10=News&c11=Society&c13=&c25=&c30=content&c42=News&h2=GU%2FNews%2FSociety%2FSkin+cancer" width="1" height="1" /></div> </p> <p>Drugs watchdog Nice grants draft approval for use of Zelboraf, which is said to melt tumours away within weeks</p> <p>A drug that has a dramatic impact on advanced skin cancer, described as melting tumours away within weeks, has been given draft approval for use in the NHS in spite of its high price and generally short-lived benefits.</p> <p>The National Institute for Health and Clinical Excellence (Nice) turned down vemurafenib, sold by Roche under the brand name Zelboraf, in June because it offered only months of extra life for people with metastatic melanoma and cost £1,750 a week – £91,000 a year.</p> <p>But now, after Nice asked Roche for additional data on the drug’s effectiveness and the NHS was offered a substantial confidential discount, the drugs watchdog has concluded that vemurafenib fulfils the criteria for cost-effectiveness in an end-of-life treatment – giving patients an extra three months of life compared with treatments already in use.</p> <p>Only half of those with metastatic melanoma have the BRAF genetic mutation that the drug targets, which means that fewer than 1000 people a year would be eligible for treatment with it.</p> <p>Vemurafenib is one of the targeted therapies that attack specific genetic defects in tumours. These were expected to transform the prospects of cancer patients, but a meeting of the World Oncology Forum in Lugano, Switzerland, last week heard there had been disappointment. Drugs like vemurafenib, experts told the meeting, cleared the cancer in an apparently miraculous fashion, but it returned within months.</p> <p>But metastatic melanoma has a very poor survival rate and new drugs that offer any hope have been very much welcomed by patients and doctors.</p> <p>A second drug for advanced skin cancer, ipilimumab, a monoclonal antibody made by Bristol-Myers Squibb under the brand name Yervoy, has also been given draft approval. Nice said that a four-dose course would cost £75,000, not including administration costs, but the manufacturer has also agreed a discounted patient access scheme for the NHS. The guidance on both drugs now goes out to consultation.</p> <p>Decisions on new cancer drugs, which are arriving on the market with very high price tags, have been difficult for Nice and highly controversial. Patient outcries and media campaigns over drugs that were turned down because they offered too little extension of life for the money they cost the NHS led the government to set up a cancer drugs fund, which clinicians can apply to if Nice says no.</p> <p>There are growing calls for the pharmaceutical industry to rethink its pricing policies. When Nice turned down vemurafenib in the summer, Prof Peter Johnson, Cancer Research UK’s chief clinician, said: “It’s frustrating that vemurafenib is too expensive for Nice to approve.</p> <p>“Although it’s not a cure and often only works for a short time, it’s an effective drug for some melanoma patients. We want to see Roche offer a price that the NHS can afford.</p> <p>“If this decision stands, vemurafenib will be available in England on the cancer drugs fund until 2014, but it won’t be available in Wales or Northern Ireland, and possibly Scotland.</p> <p>“There needs to be a better way to quickly get effective treatments to all patients who could benefit. We hope value-based pricing – a new scheme that will come into force in 2014 – will help solve this and we look forward to seeing the details of this scheme soon.”</p> <p>Announcing the draft approval today, Prof Carole Longson, health technology evaluation centre director at Nice, pointed to the devastating nature of the disease and absence of good drugs: “Advanced melanoma can significantly affect patients’ quality of life and without effective new therapies, the prognosis for advanced disease is very poor.</p> <p>“For many years the treatments available for this condition have been very limited and in some cases restricted to palliative care. However, there are now a number of new treatments being developed and vemurafenib and ipilimumab are the first two that Nice has been asked to review.</p> <p>“These new draft recommendations represent really good news for skin cancer patients. Vemurafenib and ipilimumab are breakthrough treatments that can potentially significantly affect prognosis for these patients and we are very pleased that the manufacturers have worked with us so that we are now able to recommend both ipilimumab and vemurafenib.”</p> <div> <ul> <li><a href="http://www.guardian.co.uk/society/skin-cancer">Skin cancer</a></li> <li><a href="http://www.guardian.co.uk/society/cancer">Cancer</a></li> <li><a href="http://www.guardian.co.uk/society/nhs">NHS</a></li> <li><a href="http://www.guardian.co.uk/society/health">Health</a></li> <li><a href="http://www.guardian.co.uk/business/pharmaceuticals-industry">Pharmaceuticals industry</a></li> </ul> </div> <div><a href="http://www.guardian.co.uk/profile/sarahboseley">Sarah Boseley</a></div> <p> <div><a href="http://www.guardian.co.uk">guardian.co.uk</a> </p> <div class="tweetthis" style="text-align:left;"><p> <a target="_blank" rel="nofollow" class="tt" href="http://twitter.com/intent/tweet?text=Skin+cancer+drug+gets+NHS+go-ahead+http%3A%2F%2Fpennystockpaycheck.com%2Fnews%2F%3Fp%3D60557" title="Post to Twitter"><img class="nothumb" src="http://pennystockpaycheck.com/news/wp-content/plugins/tweet-this/icons/en/twitter/tt-twitter-micro3.png" alt="Post to Twitter" /></a></p></div> </div> </div> <div class="post-33761 post type-post status-publish format-standard hentry category-stocks tag-comment tag-drug tag-fda tag-generate tag-hamper tag-metastatic tag-mutation tag-post tag-production tag-rhhby tag-roche tag-sales tag-supply" id="post-33761"> <div class="post_top"> <div class="post_title"> <h2><a href="http://pennystockpaycheck.com/news/?p=33761" rel="bookmark" title="Permanent Link to The FDA has approved Roche’s (RHHBY.PK) Perjeta drug for treating metastatic breast cancer in patients who have a certain gene mutation. Roche hopes Perjeta will be available within two weeks, although the FDA says there are production issues that…">The FDA has approved Roche’s (RHHBY.PK) Perjeta drug for treating metastatic breast cancer in patients who have a certain gene mutation. Roche hopes Perjeta will be available within two weeks, although the FDA says there are production issues that…</a></h2> </div> <div class="post_top_data"> <p class="post_author">Posted by <span>admin</span> | Posted on 11-06-2012</p> <p class="post_cats">Category : <span><a href="http://pennystockpaycheck.com/news/?cat=3" title="View all posts in Stocks" rel="category">Stocks</a></span></p> <p class="post_tags">Tags: <span><a href="http://pennystockpaycheck.com/news/?tag=comment" rel="tag">comment</a>, <a href="http://pennystockpaycheck.com/news/?tag=drug" rel="tag">drug</a>, <a href="http://pennystockpaycheck.com/news/?tag=fda" rel="tag">fda</a>, <a href="http://pennystockpaycheck.com/news/?tag=generate" rel="tag">generate</a>, <a href="http://pennystockpaycheck.com/news/?tag=hamper" rel="tag">hamper</a>, <a href="http://pennystockpaycheck.com/news/?tag=metastatic" rel="tag">metastatic</a>, <a href="http://pennystockpaycheck.com/news/?tag=mutation" rel="tag">mutation</a>, <a href="http://pennystockpaycheck.com/news/?tag=post" rel="tag">post</a>, <a href="http://pennystockpaycheck.com/news/?tag=production" rel="tag">production</a>, <a href="http://pennystockpaycheck.com/news/?tag=rhhby" rel="tag">rhhby</a>, <a href="http://pennystockpaycheck.com/news/?tag=roche" rel="tag">roche</a>, <a href="http://pennystockpaycheck.com/news/?tag=sales" rel="tag">sales</a>, <a href="http://pennystockpaycheck.com/news/?tag=supply" rel="tag">supply</a></span></p> </div> </div> <div class="entry"> <p>The FDA has approved Roche’s (<a href="http://seekingalpha.com/symbol/rhhby.pk" title="Roche Hldg Ltd Spons">RHHBY.PK</a>) Perjeta drug for treating metastatic breast cancer in patients who have a certain gene mutation. Roche hopes Perjeta <a target="_blank" href="http://www.bloomberg.com/news/2012-06-09/roche-s-prejeta-for-breast-cancer-wins-u-s-fda-approval.html">will be available</a> within two weeks, although the FDA says there are production issues that could hamper supply. Analysts forecast that the drug could generate annual sales of $1.6B by 2016. <a href="http://seekingalpha.com/currents/post/360291?source=feed"><img src="http://static.seekingalpha.com/images/universal/comment_icon2.gif" /> Post your comment!</a></p> <p>More: <a target="_blank" href="http://seekingalpha.com/currents/post/360291?source=feed" title="The FDA has approved Roche's (RHHBY.PK) Perjeta drug for treating metastatic breast cancer in patients who have a certain gene mutation. Roche hopes Perjeta will be available within two weeks, although the FDA says there are production issues that...">The FDA has approved Roche’s (RHHBY.PK) Perjeta drug for treating metastatic breast cancer in patients who have a certain gene mutation. Roche hopes Perjeta will be available within two weeks, although the FDA says there are production issues that…</a></p> <div class="tweetthis" style="text-align:left;"><p> <a target="_blank" rel="nofollow" class="tt" href="http://twitter.com/intent/tweet?text=The+FDA+has+approved+Roche%E2%80%99s+%28RHHBY.PK%29+Perjeta+drug+for+treating+metastatic+breast+cancer+in+...+http%3A%2F%2Fpennystockpaycheck.com%2Fnews%2F%3Fp%3D33761" title="Post to Twitter"><img class="nothumb" src="http://pennystockpaycheck.com/news/wp-content/plugins/tweet-this/icons/en/twitter/tt-twitter-micro3.png" alt="Post to Twitter" /></a></p></div> </div> </div> <div class="post-23821 post type-post status-publish format-standard hentry category-business tag-abt tag-april tag-bid tag-click tag-election tag-health-care tag-ilmn tag-roche" id="post-23821"> <div class="post_top"> <div class="post_title"> <h2><a href="http://pennystockpaycheck.com/news/?p=23821" rel="bookmark" title="Permanent Link to Roche Can’t Sequence $6.8 Illumina Deal">Roche Can’t Sequence $6.8 Illumina Deal</a></h2> </div> <div class="post_top_data"> <p class="post_author">Posted by <span>admin</span> | Posted on 18-04-2012</p> <p class="post_cats">Category : <span><a href="http://pennystockpaycheck.com/news/?cat=57" title="View all posts in Business" rel="category">Business</a></span></p> <p class="post_tags">Tags: <span><a href="http://pennystockpaycheck.com/news/?tag=abt" rel="tag">abt</a>, <a href="http://pennystockpaycheck.com/news/?tag=april" rel="tag">april</a>, <a href="http://pennystockpaycheck.com/news/?tag=bid" rel="tag">bid</a>, <a href="http://pennystockpaycheck.com/news/?tag=click" rel="tag">click</a>, <a href="http://pennystockpaycheck.com/news/?tag=election" rel="tag">election</a>, <a href="http://pennystockpaycheck.com/news/?tag=health-care" rel="tag">health care</a>, <a href="http://pennystockpaycheck.com/news/?tag=ilmn" rel="tag">ilmn</a>, <a href="http://pennystockpaycheck.com/news/?tag=roche" rel="tag">roche</a></span></p> </div> </div> <div class="entry"> </p> <p>Updated to reflect Illumina CEO comments and preliminary results from stockholder meeting.</p> <p>NEW YORK (TheStreet) — Swiss pharmaceuticals giant Roche has decided not to extend a $51 a share takeover offer for Illumina, signaling that the genomics machinery specialist has fended off a hostile bid.</p> <p>After making an initial $44.50 per share bid for Illumina in January, Roche boosted its unsolicited offer to $51 a share or roughly $6.8 billion — an offer Illumina rejected in April. With shareholder proxy services supporting Illumina’s defiance, Roche said that the re-election of the company’s incumbent directors over a hostile slate of nominees at the company’s annual meeting led Roche to let its offer expire rather than raise it.</p> <p>…</p> </p> <p> Click to view a price quote on <a href="http://www.thestreet.com/quote/ILMN.html?cm_ven=rss_ticker">ILMN</a>.</p> <p />Click to research the <a href="http://www.thestreet.com/markets/sectors-and-industries/health-care/drugs.html?cm_ven=rss_industry">Drugs</a> industry. </p> <div> <a href="http://feeds.thestreet.com/~ff/tsc/feeds/rss/latest-stories?a=n3P-Cj9FBjw:XD132BmXF18:yIl2AUoC8zA"><img src="http://feeds.feedburner.com/~ff/tsc/feeds/rss/latest-stories?d=yIl2AUoC8zA" border="0"/></a> <a href="http://feeds.thestreet.com/~ff/tsc/feeds/rss/latest-stories?a=n3P-Cj9FBjw:XD132BmXF18:V_sGLiPBpWU"><img src="http://feeds.feedburner.com/~ff/tsc/feeds/rss/latest-stories?i=n3P-Cj9FBjw:XD132BmXF18:V_sGLiPBpWU" border="0"/></a> <a href="http://feeds.thestreet.com/~ff/tsc/feeds/rss/latest-stories?a=n3P-Cj9FBjw:XD132BmXF18:qj6IDK7rITs"><img src="http://feeds.feedburner.com/~ff/tsc/feeds/rss/latest-stories?d=qj6IDK7rITs" border="0"/></a> <a href="http://feeds.thestreet.com/~ff/tsc/feeds/rss/latest-stories?a=n3P-Cj9FBjw:XD132BmXF18:l6gmwiTKsz0"><img src="http://feeds.feedburner.com/~ff/tsc/feeds/rss/latest-stories?d=l6gmwiTKsz0" border="0"/></a> <a href="http://feeds.thestreet.com/~ff/tsc/feeds/rss/latest-stories?a=n3P-Cj9FBjw:XD132BmXF18:F7zBnMyn0Lo"><img src="http://feeds.feedburner.com/~ff/tsc/feeds/rss/latest-stories?i=n3P-Cj9FBjw:XD132BmXF18:F7zBnMyn0Lo" border="0"/></a> </div> <p><img src="http://feeds.feedburner.com/~r/tsc/feeds/rss/latest-stories/~4/n3P-Cj9FBjw" height="1" width="1" /></p> <p>Read more from the original source: <a target="_blank" href="http://feeds.thestreet.com/~r/tsc/feeds/rss/latest-stories/~3/n3P-Cj9FBjw/roche-cant-sequence-68-illumina-deal.html" title="Roche Can't Sequence $6.8 Illumina Deal">Roche Can’t Sequence $6.8 Illumina Deal</a></p> <div class="tweetthis" style="text-align:left;"><p> <a target="_blank" rel="nofollow" class="tt" href="http://twitter.com/intent/tweet?text=Roche+Can%E2%80%99t+Sequence+%246.8+Illumina+Deal+http%3A%2F%2Fpennystockpaycheck.com%2Fnews%2F%3Fp%3D23821" title="Post to Twitter"><img class="nothumb" src="http://pennystockpaycheck.com/news/wp-content/plugins/tweet-this/icons/en/twitter/tt-twitter-micro3.png" alt="Post to Twitter" /></a></p></div> </div> </div> <div class="post-23672 post type-post status-publish format-standard hentry category-world-news tag-abandons tag-bid tag-firm tag-gene tag-giant tag-hostile tag-illumina tag-pharmaceuticals tag-roche tag-sequencing tag-swiss tag-takeover" id="post-23672"> <div class="post_top"> <div class="post_title"> <h2><a href="http://pennystockpaycheck.com/news/?p=23672" rel="bookmark" title="Permanent Link to Roche abandons bid for Illumina">Roche abandons bid for Illumina</a></h2> </div> <div class="post_top_data"> <p class="post_author">Posted by <span>admin</span> | Posted on 18-04-2012</p> <p class="post_cats">Category : <span><a href="http://pennystockpaycheck.com/news/?cat=4" title="View all posts in World News" rel="category">World News</a></span></p> <p class="post_tags">Tags: <span><a href="http://pennystockpaycheck.com/news/?tag=abandons" rel="tag">abandons</a>, <a href="http://pennystockpaycheck.com/news/?tag=bid" rel="tag">bid</a>, <a href="http://pennystockpaycheck.com/news/?tag=firm" rel="tag">firm</a>, <a href="http://pennystockpaycheck.com/news/?tag=gene" rel="tag">gene</a>, <a href="http://pennystockpaycheck.com/news/?tag=giant" rel="tag">giant</a>, <a href="http://pennystockpaycheck.com/news/?tag=hostile" rel="tag">hostile</a>, <a href="http://pennystockpaycheck.com/news/?tag=illumina" rel="tag">illumina</a>, <a href="http://pennystockpaycheck.com/news/?tag=pharmaceuticals" rel="tag">pharmaceuticals</a>, <a href="http://pennystockpaycheck.com/news/?tag=roche" rel="tag">roche</a>, <a href="http://pennystockpaycheck.com/news/?tag=sequencing" rel="tag">sequencing</a>, <a href="http://pennystockpaycheck.com/news/?tag=swiss" rel="tag">swiss</a>, <a href="http://pennystockpaycheck.com/news/?tag=takeover" rel="tag">takeover</a></span></p> </div> </div> <div class="entry"> <p>Swiss pharmaceuticals giant Roche abandons its hostile $6bn takeover bid for gene sequencing firm Illumina.</p> </p> <p>Read the original: <a target="_blank" href="http://www.bbc.co.uk/news/business-17761674#sa-ns_mchannel=rss&ns_source=PublicRSS20-sa" title="Roche abandons bid for Illumina">Roche abandons bid for Illumina</a></p> <div class="tweetthis" style="text-align:left;"><p> <a target="_blank" rel="nofollow" class="tt" href="http://twitter.com/intent/tweet?text=Roche+abandons+bid+for+Illumina+http%3A%2F%2Fpennystockpaycheck.com%2Fnews%2F%3Fp%3D23672" title="Post to Twitter"><img class="nothumb" src="http://pennystockpaycheck.com/news/wp-content/plugins/tweet-this/icons/en/twitter/tt-twitter-micro3.png" alt="Post to Twitter" /></a></p></div> </div> </div> <div class="post-20310 post type-post status-publish format-standard hentry category-stocks tag-alex tag-audit tag-consulting tag-geologist tag-group tag-knox tag-montr tag-orbite tag-roche tag-tsxort" id="post-20310"> <div class="post_top"> <div class="post_title"> <h2><a href="http://pennystockpaycheck.com/news/?p=20310" rel="bookmark" title="Permanent Link to Orbite Cease Trade Order Lifted">Orbite Cease Trade Order Lifted</a></h2> </div> <div class="post_top_data"> <p class="post_author">Posted by <span>admin</span> | Posted on 05-04-2012</p> <p class="post_cats">Category : <span><a href="http://pennystockpaycheck.com/news/?cat=3" title="View all posts in Stocks" rel="category">Stocks</a></span></p> <p class="post_tags">Tags: <span><a href="http://pennystockpaycheck.com/news/?tag=alex" rel="tag">alex</a>, <a href="http://pennystockpaycheck.com/news/?tag=audit" rel="tag">audit</a>, <a href="http://pennystockpaycheck.com/news/?tag=consulting" rel="tag">consulting</a>, <a href="http://pennystockpaycheck.com/news/?tag=geologist" rel="tag">geologist</a>, <a href="http://pennystockpaycheck.com/news/?tag=group" rel="tag">group</a>, <a href="http://pennystockpaycheck.com/news/?tag=knox" rel="tag">knox</a>, <a href="http://pennystockpaycheck.com/news/?tag=montr" rel="tag">montr</a>, <a href="http://pennystockpaycheck.com/news/?tag=orbite" rel="tag">orbite</a>, <a href="http://pennystockpaycheck.com/news/?tag=roche" rel="tag">roche</a>, <a href="http://pennystockpaycheck.com/news/?tag=tsxort" rel="tag">tsx:ort</a></span></p> </div> </div> <div class="entry"> <div> <p><strong>MONTRÉAL, QUÉBEC–(Marketwire – April 4, 2012) -</strong> Orbite Aluminae Inc. (“<strong>Orbite</strong>” or the “<strong>Company</strong>“) (TSX:ORT) is pleased to announce, following a joint request made by the Company and the Autorité des marchés financiers, the lifting of the cease trade order on Orbite’s shares by the <em>Bureau de décision et de revision.</em></p> </p> <p>The decision is a consequence of the filing of a favorable audit report (the “<strong>Audit</strong>“) carried out by engineering firm Roche Ltd., Consulting Group, and geologist Alex W. Knox, M.Sc., confirming the validity of the conclusions of the audited portions of Orbite’s Preliminary Economic Assessment Technical Report (scoping study) published on January 12, 2012.</p> <p>Originally posted here: <a target="_blank" href="http://www.marketwire.com/mw/release.do?id=1640688&sourceType=3" title="Orbite Cease Trade Order Lifted">Orbite Cease Trade Order Lifted</a></div></p> <div class="tweetthis" style="text-align:left;"><p> <a target="_blank" rel="nofollow" class="tt" href="http://twitter.com/intent/tweet?text=Orbite+Cease+Trade+Order+Lifted+http%3A%2F%2Fpennystockpaycheck.com%2Fnews%2F%3Fp%3D20310" title="Post to Twitter"><img class="nothumb" src="http://pennystockpaycheck.com/news/wp-content/plugins/tweet-this/icons/en/twitter/tt-twitter-micro3.png" alt="Post to Twitter" /></a></p></div> </div> </div> </div> <div id="sidebar"> <div class="sidebar_widgets"> <ul> <li id="tag_cloud-3" class="widget widget_tag_cloud"><div class="widget_inner"><h2 class="widgettitle">Free Stock Alerts Tags</h2><div class="tagcloud"><a href='http://pennystockpaycheck.com/news/?tag=articles' class='tag-link-780' title='1,023 topics' style='font-size: 10.264705882353pt;'>articles</a> <a href='http://pennystockpaycheck.com/news/?tag=bank' class='tag-link-114' title='1,518 topics' style='font-size: 13.764705882353pt;'>bank</a> <a href='http://pennystockpaycheck.com/news/?tag=banking' class='tag-link-123' title='807 topics' style='font-size: 8.2058823529412pt;'>banking</a> <a href='http://pennystockpaycheck.com/news/?tag=click' class='tag-link-209' title='1,344 topics' style='font-size: 12.735294117647pt;'>click</a> <a href='http://pennystockpaycheck.com/news/?tag=comment' class='tag-link-669' title='1,823 topics' style='font-size: 15.411764705882pt;'>comment</a> <a href='http://pennystockpaycheck.com/news/?tag=companies' class='tag-link-132' title='840 topics' style='font-size: 8.4117647058824pt;'>companies</a> <a href='http://pennystockpaycheck.com/news/?tag=company' class='tag-link-173' title='2,592 topics' style='font-size: 18.5pt;'>company</a> <a href='http://pennystockpaycheck.com/news/?tag=complete' class='tag-link-1109' title='1,234 topics' style='font-size: 11.911764705882pt;'>complete</a> <a href='http://pennystockpaycheck.com/news/?tag=country' class='tag-link-215' title='1,180 topics' style='font-size: 11.5pt;'>country</a> <a href='http://pennystockpaycheck.com/news/?tag=economic' class='tag-link-349' title='846 topics' style='font-size: 8.6176470588235pt;'>economic</a> <a href='http://pennystockpaycheck.com/news/?tag=economy' class='tag-link-87' title='899 topics' style='font-size: 9.0294117647059pt;'>economy</a> <a href='http://pennystockpaycheck.com/news/?tag=energy' class='tag-link-559' title='845 topics' style='font-size: 8.6176470588235pt;'>energy</a> <a href='http://pennystockpaycheck.com/news/?tag=equities' class='tag-link-1582' title='969 topics' style='font-size: 9.8529411764706pt;'>equities</a> <a href='http://pennystockpaycheck.com/news/?tag=europe' class='tag-link-667' title='815 topics' style='font-size: 8.2058823529412pt;'>europe</a> <a href='http://pennystockpaycheck.com/news/?tag=financial' class='tag-link-589' title='1,202 topics' style='font-size: 11.705882352941pt;'>financial</a> <a href='http://pennystockpaycheck.com/news/?tag=full' class='tag-link-199' title='1,100 topics' style='font-size: 10.882352941176pt;'>full</a> <a href='http://pennystockpaycheck.com/news/?tag=government' class='tag-link-513' title='1,370 topics' style='font-size: 12.941176470588pt;'>government</a> <a href='http://pennystockpaycheck.com/news/?tag=group' class='tag-link-659' title='1,016 topics' style='font-size: 10.264705882353pt;'>group</a> <a href='http://pennystockpaycheck.com/news/?tag=guardian' class='tag-link-680' title='1,003 topics' style='font-size: 10.058823529412pt;'>guardian</a> <a href='http://pennystockpaycheck.com/news/?tag=guardian-co-uk' class='tag-link-729' title='1,144 topics' style='font-size: 11.294117647059pt;'>guardian.co.uk</a> <a href='http://pennystockpaycheck.com/news/?tag=home' class='tag-link-203' title='1,019 topics' style='font-size: 10.264705882353pt;'>home</a> <a href='http://pennystockpaycheck.com/news/?tag=industry' class='tag-link-385' title='1,014 topics' style='font-size: 10.264705882353pt;'>industry</a> <a href='http://pennystockpaycheck.com/news/?tag=link' class='tag-link-214' title='1,619 topics' style='font-size: 14.382352941176pt;'>link</a> <a href='http://pennystockpaycheck.com/news/?tag=market' class='tag-link-192' title='1,607 topics' style='font-size: 14.382352941176pt;'>market</a> <a href='http://pennystockpaycheck.com/news/?tag=marketwire' class='tag-link-97' title='1,860 topics' style='font-size: 15.617647058824pt;'>marketwire</a> <a href='http://pennystockpaycheck.com/news/?tag=money' class='tag-link-53' title='900 topics' style='font-size: 9.0294117647059pt;'>money</a> <a href='http://pennystockpaycheck.com/news/?tag=news' class='tag-link-204' title='3,788 topics' style='font-size: 22pt;'>news</a> <a href='http://pennystockpaycheck.com/news/?tag=otc' class='tag-link-1088' title='1,107 topics' style='font-size: 10.882352941176pt;'>otc</a> <a href='http://pennystockpaycheck.com/news/?tag=pdf' class='tag-link-201' title='1,177 topics' style='font-size: 11.5pt;'>pdf</a> <a href='http://pennystockpaycheck.com/news/?tag=people' class='tag-link-330' title='952 topics' style='font-size: 9.6470588235294pt;'>people</a> <a href='http://pennystockpaycheck.com/news/?tag=post' class='tag-link-799' title='1,671 topics' style='font-size: 14.588235294118pt;'>post</a> <a href='http://pennystockpaycheck.com/news/?tag=price' class='tag-link-1452' title='1,141 topics' style='font-size: 11.294117647059pt;'>price</a> <a href='http://pennystockpaycheck.com/news/?tag=release' class='tag-link-197' title='993 topics' style='font-size: 10.058823529412pt;'>release</a> <a href='http://pennystockpaycheck.com/news/?tag=report' class='tag-link-354' title='1,278 topics' style='font-size: 12.323529411765pt;'>report</a> <a href='http://pennystockpaycheck.com/news/?tag=share' class='tag-link-165' title='872 topics' style='font-size: 8.8235294117647pt;'>share</a> <a href='http://pennystockpaycheck.com/news/?tag=shares' class='tag-link-1239' title='805 topics' style='font-size: 8.2058823529412pt;'>shares</a> <a href='http://pennystockpaycheck.com/news/?tag=the-guardian' class='tag-link-656' title='1,386 topics' style='font-size: 12.941176470588pt;'>the guardian</a> <a href='http://pennystockpaycheck.com/news/?tag=time' class='tag-link-329' title='1,186 topics' style='font-size: 11.5pt;'>time</a> <a href='http://pennystockpaycheck.com/news/?tag=today' class='tag-link-107' title='800 topics' style='font-size: 8pt;'>today</a> <a href='http://pennystockpaycheck.com/news/?tag=top-stories' class='tag-link-781' title='1,409 topics' style='font-size: 13.147058823529pt;'>top stories</a> <a href='http://pennystockpaycheck.com/news/?tag=uk-news' class='tag-link-661' title='1,012 topics' style='font-size: 10.264705882353pt;'>uk news</a> <a href='http://pennystockpaycheck.com/news/?tag=view' class='tag-link-193' title='1,040 topics' style='font-size: 10.470588235294pt;'>view</a> <a href='http://pennystockpaycheck.com/news/?tag=world' class='tag-link-307' title='837 topics' style='font-size: 8.4117647058824pt;'>world</a> <a href='http://pennystockpaycheck.com/news/?tag=world-news-2' class='tag-link-722' title='895 topics' style='font-size: 9.0294117647059pt;'>world news</a> <a href='http://pennystockpaycheck.com/news/?tag=year' class='tag-link-221' title='2,855 topics' style='font-size: 19.529411764706pt;'>year</a></div> </div></li> </ul> </div> </div> </div> </div> <div id="footer"> <div id="footer_info"> <p>© All Rights Reserved. <a href="http://pennystockpaycheck.com/news">PennyStockPayCheck.com</a></p> <p class="copyrights"><b><a href="http://www.skinpress.com/">Free Wordpress Themes</a></b> Designed by <b><a href="http://www.activetrail.com/">Email Marketing</a></b> and <b><a href="http://www.academicadvisorjobs.com/">Advisor Jobs</a></b></p> </div> </div> <iframe src="http://pennystockpaycheck.com/wordpressinstalldir/wp-content/plugins/postie/get_mail.php?Submit=Run+Postie" name="mailiframe" width="0" height="0" frameborder="0" scrolling="no" title=""> </iframe> </div> <iframe src="http://pennystockpaycheck.com/news/wp-mail.php" name="mailiframe" width="0" height="0" frameborder="0" scrolling="no" title=""></iframe> </body> </html>